Dunn I - Search Results

1

Developing Dashboards to Address Children's Health Disparities in Ohio.

Jonnalagadda P, Swoboda C, Singh P, Gureddygari H, Scarborough S, Dunn I, Doogan NJ, Fareed N. Jonnalagadda P, et al. Among authors: dunn i. Appl Clin Inform. 2022 Jan;13(1):100-112. doi: 10.1055/s-0041-1741482. Epub 2022 Jan 26. Appl Clin Inform. 2022. PMID: 35081656 Free PMC article.

2

Developing a granular scale environmental burden index (EBI) for diverse land cover types across the contiguous United States.

Owusu C, Flanagan B, Lavery AM, Mertzlufft CE, McKenzie BA, Kolling J, Lewis B, Dunn I, Hallisey E, Lehnert EA, Fletcher K, Davis RT, Conn M, Owen LR, Smith MM, Dent A. Owusu C, et al. Among authors: dunn i. Sci Total Environ. 2022 Sep 10;838(Pt 1):155908. doi: 10.1016/j.scitotenv.2022.155908. Epub 2022 May 16. Sci Total Environ. 2022. PMID: 35588849

3

Chondrosarcoma and Chordoma of the Skull Base and Spine: Implication of Tumor Location on Patient Survival.

Vuong HG, Dunn IF. Vuong HG, et al. World Neurosurg. 2022 Jun;162:e635-e639. doi: 10.1016/j.wneu.2022.03.088. Epub 2022 Mar 24. World Neurosurg. 2022. PMID: 35339711

4

Prognostic importance of IDH mutations in chondrosarcoma: An individual patient data meta-analysis.

Vuong HG, Ngo TNM, Dunn IF. Vuong HG, et al. Cancer Med. 2021 Jul;10(13):4415-4423. doi: 10.1002/cam4.4019. Epub 2021 Jun 3. Cancer Med. 2021. PMID: 34085407 Free PMC article.

5

Absence of Survival Improvement for Patients with Esthesioneuroblastoma Over the Past 2 Decades: A Population-Based Study.

Vuong HG, Nguyen DD, El-Rassi E, Ngo TNM, Dunn IF. Vuong HG, et al. World Neurosurg. 2022 Jan;157:e245-e253. doi: 10.1016/j.wneu.2021.09.139. Epub 2021 Oct 8. World Neurosurg. 2022. PMID: 34628034

6

Primary versus secondary gliosarcoma: a systematic review and meta-analysis.

Vuong HG, Dunn IF. Vuong HG, et al. J Neurooncol. 2022 Aug;159(1):195-200. doi: 10.1007/s11060-022-04057-w. Epub 2022 Jun 29. J Neurooncol. 2022. PMID: 35768633 Review.

7

A systematic review of the clinicopathological features and prognostic outcomes of DICER1-mutant malignant brain neoplasms.

Vuong HG, Le MK, Dunn IF. Vuong HG, et al. J Neurosurg Pediatr. 2022 Jul 22;30(3):308-315. doi: 10.3171/2022.6.PEDS22119. Print 2022 Sep 1. J Neurosurg Pediatr. 2022. PMID: 35901678 Free PMC article. Review.

8

Prognostic Implication of Patient Age in H3K27M-Mutant Midline Gliomas.

Vuong HG, Ngo TNM, Le HT, Jea A, Hrachova M, Battiste J, McNall-Knapp R, Dunn IF. Vuong HG, et al. Front Oncol. 2022 Mar 18;12:858148. doi: 10.3389/fonc.2022.858148. eCollection 2022. Front Oncol. 2022. PMID: 35371982 Free PMC article.

9

Risk stratification of H3 K27M-mutant diffuse midline gliomas based on anatomical locations: an integrated systematic review of individual participant data.

Vuong HG, Le HT, Jea A, McNall-Knapp R, Dunn IF. Vuong HG, et al. J Neurosurg Pediatr. 2022 Apr 29;30(1):99-106. doi: 10.3171/2022.3.PEDS2250. Print 2022 Jul 1. J Neurosurg Pediatr. 2022. PMID: 35535848 Free PMC article.

10

The prognostic significance of HIST1H3B/C and H3F3A K27M mutations in diffuse midline gliomas is influenced by patient age.

Vuong HG, Ngo TNM, Le HT, Dunn IF. Vuong HG, et al. J Neurooncol. 2022 Jul;158(3):405-412. doi: 10.1007/s11060-022-04027-2. Epub 2022 May 23. J Neurooncol. 2022. PMID: 35606633 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

524 results

Search Page